Crystal Lake, Illinois, April 3, 2020 - AptarGroup, Inc. (NYSE: ATR), a global leader in drug
delivery, consumer product dispensing and active
packaging solutions, is seeking U.S. FDA Emergency
Use Authorization (EUA) for a solution that allows easy
disinfecting of N95 filtering facepiece respirators (N95
mask). The N95 masks are desperately needed by
healthcare personnel due to the shortage of disposable
masks during the COVID-19 pandemic.
